Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Nguyen, Holly M; Corey, Eva (2011) Methodology to investigate androgen-sensitive and castration-resistant human prostate cancer xenografts in preclinical setting. Methods Mol Biol 776:295-312
Roudier, Martine P; Morrissey, Colm; True, Lawrence D et al. (2008) Histopathological assessment of prostate cancer bone osteoblastic metastases. J Urol 180:1154-60
Pfitzenmaier, Jesco; Ellis, William J; Arfman, Edward W et al. (2006) Telomerase activity in disseminated prostate cancer cells. BJU Int 97:1309-13
Roudier, M P; True, L D; Vessella, R L et al. (2004) Metastatic conventional prostatic adenocarcinoma with diffuse chromogranin A and androgen receptor positivity. J Clin Pathol 57:321-3
Roudier, Martine P; Corey, Eva; True, Lawrence D et al. (2004) Histological, immunophenotypic and histomorphometric characterization of prostate cancer bone metastases. Cancer Treat Res 118:311-39
Brubaker, K D; Corey, E; Brown, L G et al. (2004) Bone morphogenetic protein signaling in prostate cancer cell lines. J Cell Biochem 91:151-60
Blaszczyk, Natalie; Masri, Bassam A; Mawji, Nasrin R et al. (2004) Osteoblast-derived factors induce androgen-independent proliferation and expression of prostate-specific antigen in human prostate cancer cells. Clin Cancer Res 10:1860-9
Roudier, M P; Vesselle, H; True, L D et al. (2003) Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy results. Clin Exp Metastasis 20:171-80
Meehan, Katie L; Sadar, Marianne D (2003) Androgens and androgen receptor in prostate and ovarian malignancies. Front Biosci 8:d780-800
Corey, Eva; Quinn, Janna E; Buhler, Kent R et al. (2003) LuCaP 35: a new model of prostate cancer progression to androgen independence. Prostate 55:239-46

Showing the most recent 10 out of 48 publications